Exelixis raises $71.8 million through stock offering

South San Francisco-based biotechnology company Exelixis Inc. (EXEL) said it has netted approximately $71.8 million through its public offering of 7 million shares of common stock.

Underwriter Goldman, Sachs & Co. has also been granted a 30-day option to purchase up to an additional 1.05 million shares of common stock.

businessBusiness & Real Estate

If you find our journalism valuable and relevant, please consider joining our Examiner membership program.
Find out more at www.sfexaminer.com/join/

Just Posted

Supes approve $13.6B city budget in a 10-1 vote

Supervisor Stefani calls proposal ‘fiscally irresponsible’ in lone ‘nay’ vote

Filipino immersion proposal meets with resistance from school district

Bessie Carmichael parents say current program failing to teach language proficiency

Full lineup of Hardly Strictly Bluegrass announced

20th anniversary roots music festival streams on Oct. 3

Judge will rule later this week on shortening time frame for U.S. census data collection

A federal judge in San Jose heard arguments Tuesday on a preliminary… Continue reading

Most Read